logo
  

EARNINGS SUMMARY: Details of Nektar Therapeutics Q2 Earnings Report

Below are the earnings highlights for Nektar Therapeutics (NKTR):

-Earnings: -$125.52 million in Q2 vs. -$80.00 million in the same period last year.
-EPS: -$0.69 in Q2 vs. -$0.45 in the same period last year.
-Analysts projected -$0.74 per share
-Revenue: $28.33 million in Q2 vs. $48.85 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT